| Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan, AA Sule, R Tirupathi, ... Vaccines 9 (5), 436, 2021 | 251 | 2021 |
| Knowledge of infection prevention and control among healthcare workers and factors influencing compliance: a systematic review S Alhumaid, A Al Mutair, Z Al Alawi, M Alsuliman, GY Ahmed, AA Rabaan, ... Antimicrobial Resistance & Infection Control 10 (1), 86, 2021 | 233 | 2021 |
| Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies K Dhama, F Nainu, A Frediansyah, MI Yatoo, RK Mohapatra, ... Journal of infection and public health 16 (1), 4-14, 2023 | 228 | 2023 |
| Viral dynamics and real-time RT-PCR Ct values correlation with disease severity in COVID-19 AA Rabaan, R Tirupathi, AA Sule, J Aldali, AA Mutair, S Alhumaid, ... Diagnostics 11 (6), 1091, 2021 | 227 | 2021 |
| COVID-19 and mucormycosis superinfection: the perfect storm JA Al-Tawfiq, S Alhumaid, AN Alshukairi, MH Temsah, M Barry, ... Infection 49, 833-853, 2021 | 181 | 2021 |
| COVID-19 vaccine hesitancy–reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic K Dhama, K Sharun, R Tiwari, M Dhawan, TB Emran, AA Rabaan, ... Human Vaccines & Immunotherapeutics 17 (10), 3495-3499, 2021 | 159 | 2021 |
| Monkeypox and its possible sexual transmission: where are we now with its evidence? R Sah, A Abdelaal, A Reda, BE Katamesh, E Manirambona, ... Pathogens 11 (8), 924, 2022 | 129 | 2022 |
| Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders–Advances and challenges TK Goswami, M Singh, M Dhawan, S Mitra, TB Emran, AA Rabaan, ... Human vaccines & immunotherapeutics 18 (1), 2035117, 2022 | 119 | 2022 |
| The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis A Al-Omari, A Al Mutair, S Alhumaid, S Salih, A Alanazi, H Albarsan, ... Antimicrobial Resistance & Infection Control 9 (1), 95, 2020 | 113 | 2020 |
| Global prevalence and potential influencing factors of COVID-19 vaccination hesitancy: a meta-analysis JK Fajar, M Sallam, G Soegiarto, YJ Sugiri, M Anshory, L Wulandari, ... Vaccines 10 (8), 1356, 2022 | 108 | 2022 |
| Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols AA Rabaan, SH Al-Ahmed, M Al-Malkey, R Alsubki, S Ezzikouri, ... Royal College of Surgeons in Ireland, 2022 | 96 | 2022 |
| Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: a descriptive cross-sectional study A Al-Omari, WN Alhuqbani, ARZ Zaidi, MF Al-Subaie, AM AlHindi, ... Journal of infection and public health 13 (11), 1639-1644, 2020 | 96 | 2020 |
| Antibiotics in the pipeline: a literature review (2017–2020) JA Al-Tawfiq, H Momattin, AY Al-Ali, K Eljaaly, R Tirupathi, MB Haradwala, ... Infection, 1-12, 2022 | 87 | 2022 |
| Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study A Al Mutair, S Alhumaid, WN Alhuqbani, ARZ Zaidi, S Alkoraisi, ... European Journal of Medical Research 25, 1-8, 2020 | 87 | 2020 |
| Application of artificial intelligence in combating high antimicrobial resistance rates AA Rabaan, S Alhumaid, AA Mutair, M Garout, Y Abulhamayel, ... Antibiotics 11 (6), 784, 2022 | 83 | 2022 |
| Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine storm and … AA Rabaan, SH Al-Ahmed, MA Garout, AM Al-Qaaneh, AA Sule, ... Pathogens 10 (5), 565, 2021 | 83 | 2021 |
| Update on the omicron sub‐variants BA. 4 and BA. 5 TE Tallei, S Alhumaid, Z AlMusa, Fatimawali, D Kusumawaty, A Alynbiawi, ... Reviews in medical virology 33 (1), e2391, 2023 | 80 | 2023 |
| COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges K Dhama, M Dhawan, R Tiwari, TB Emran, S Mitra, AA Rabaan, ... Human vaccines & immunotherapeutics 18 (5), 2045853, 2022 | 80 | 2022 |
| Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis S Alhumaid, A Al Mutair, Z Al Alawi, AA Rabaan, R Tirupathi, MA Alomari, ... Allergy, Asthma & Clinical Immunology 17, 1-24, 2021 | 71 | 2021 |
| Preventing the next pandemic: is live vaccine efficacious against monkeypox, or is there a need for killed virus and mRNA vaccines? A Abdelaal, A Reda, BI Lashin, BE Katamesh, AM Brakat, ... Vaccines 10 (9), 1419, 2022 | 63 | 2022 |
